Tie-up with Serum Institute of India key to mass production of COVID vaccines, say two pharma majors
Covishield is less expensive compared to some of the other vaccines being used — such as the ones from Pfizer-BioNTech and Moderna.
Full Article
Tie-up with Serum Institute of India key to mass production of COVID vaccines, say two pharma majors
Hindu
0 shares
1 views
You might like
Related news coverage
The Great Game Of Vaccination Diplomacy Targets Africa – OpEd
Russia is committed to helping eradicate the rapidly increasing coronavirus infections in Africa amounting to approximately 3.8..
Eurasia Review
Latin America Finds Its Own Answers To Produce COVID-19 Vaccines And Save Lives – OpEd
By Rubén Sierra*
In a world harmed by the severe COVID-19 pandemic, the access to vaccines is being distorted by the..
Eurasia Review